Michael Russell Mullane

Michael Mullane practices at John H. Stroger, Jr. Hospital of Cook County in Chicago, Illinois, part of Cook County Government.

Michael Mullane's NPI, 1386665081, was assigned on July 21, 2006. Michael Mullane graduated from Wayne State University School of Medicine in 1982. Michael Mullane holds Illinois license 036-068847.

Michael Mullane's primary practice is John H. Stroger, Jr. Hospital of Cook County, at 1901 W Harrison St, Chicago, IL 60612 in Cook County. The practice phone is (312) 864-6000.

Michael Mullane's primary practice is John H. Stroger, Jr. Hospital of Cook County in Chicago, Illinois, part of Cook County Government. Michael Mullane is also affiliated with Provident Hospital of Cook County Health. The medical group on file is John H. Stroger, Jr. Hospital of Cook County. Dmand AI also links Michael Mullane to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Mullane practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Michael Mullane's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Michael Mullane is licensed in Illinois.

CMS data shows 203 Medicare services from Michael Mullane across 2 procedure codes in 2024, all of them office visits, for 105 Medicare patients. Medicare paid $13,896 for them. Every service was in an office.

CMS counts 105 Medicare patients who saw Michael Mullane in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have cancer, and 72% have high blood pressure. 71% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Mullane's median patient age at 71, with 42% women.

In 2024, Michael Mullane wrote 918 Medicare Part D claims for 94 patients. 87% of them were for generic drugs. CMS names the drug for 651 of them, across 31 drugs with 11 or more claims each, at $686,511 in total drug cost. In 2023, CMS named 738 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Michael Mullane for performance year 2024, reported as part of a group. Michael Mullane accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 37 general payments to Michael Mullane from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 37% of the total. Novartis Pharmaceuticals Corporation paid the most, $1,005.

Michael Mullane graduated from Wayne State University School of Medicine in 1982.